170 related articles for article (PubMed ID: 27819522)
21. Autoantibodies to thrombopoietin and the thrombopoietin receptor in patients with immune thrombocytopenia.
Nazy I; Kelton JG; Moore JC; Clare R; Horsewood P; Smith JW; Ivetic N; D'Souza V; Li N; Arnold DM
Br J Haematol; 2018 Apr; 181(2):234-241. PubMed ID: 29532903
[TBL] [Abstract][Full Text] [Related]
22. Circulating microRNAs in patients with immune thrombocytopenia before and after treatment with thrombopoietin-receptor agonists.
Garabet L; Ghanima W; Rangberg A; Teruel-Montoya R; Martinez C; Lozano ML; Nystrand CF; Bussel JB; Sandset PM; Jonassen CM
Platelets; 2020; 31(2):198-205. PubMed ID: 30885035
[TBL] [Abstract][Full Text] [Related]
23. Significance of chemokines and soluble CD40 ligand in patients with autoimmune thrombocytopenic purpura.
Nagahama M; Nomura S; Kanazawa S; Ozaki Y; Kagawa H; Fukuhara S
Eur J Haematol; 2002; 69(5-6):303-8. PubMed ID: 12460235
[TBL] [Abstract][Full Text] [Related]
24. The use of thrombopoietin-receptor agonists (TPO-RAs) in immune thrombocytopenia (ITP): a "real life" retrospective multicenter experience of the Rete Ematologica Pugliese (REP).
Mazza P; Minoia C; Melpignano A; Polimeno G; Cascavilla N; Di Renzo N; Specchia G
Ann Hematol; 2016 Jan; 95(2):239-44. PubMed ID: 26596973
[TBL] [Abstract][Full Text] [Related]
25. Effect of a thrombopoietin receptor agonist on use of intravenous immune globulin in patients with immune thrombocytopenia.
Zeller MP; Heddle NM; Kelton JG; Hamilton K; Wang G; Sholapur N; Carruthers J; Hsia C; Blais N; Toltl L; Hamm C; Pearson MA; Arnold DM
Transfusion; 2016 Jan; 56(1):73-9. PubMed ID: 26400824
[TBL] [Abstract][Full Text] [Related]
26. Plasma thrombopoietin levels in patients with aplastic anemia and idiopathic thrombocytopenic purpura.
Gu J; Lu L; Xu R; Chen X
Chin Med J (Engl); 2002 Jul; 115(7):983-6. PubMed ID: 12150725
[TBL] [Abstract][Full Text] [Related]
27. Reduced expression of transforming growth factor-β1 and correlated elevation of interleukin-17 and interferon-γ in pediatric patients with chronic primary immune thrombocytopenia (ITP).
Wang JD; Chang TK; Lin HK; Huang FL; Wang CJ; Lee HJ
Pediatr Blood Cancer; 2011 Oct; 57(4):636-40. PubMed ID: 21721104
[TBL] [Abstract][Full Text] [Related]
28. [Thrombosis during thrombopoietin receptor agonist treatment for immune thrombocytopenia. A French multicentric observational study].
Weber E; Moulis G; Mahévas M; Guy C; Lioger B; Durieu I; Hunault M; Ramanantsoa M; Royer B; Default A; Pérault-Pochat MC; Moachon L; Bernard N; Bardy G; Jonville-Bera AP; Geniaux H; Godeau B; Cathébras P
Rev Med Interne; 2017 Mar; 38(3):167-175. PubMed ID: 27793553
[TBL] [Abstract][Full Text] [Related]
29. Effect of thrombopoietin receptor agonists on the apoptotic profile of platelets in patients with chronic immune thrombocytopenia.
Mitchell WB; Pinheiro MP; Boulad N; Kaplan D; Edison MN; Psaila B; Karpoff M; White MJ; Josefsson EC; Kile BT; Bussel JB
Am J Hematol; 2014 Dec; 89(12):E228-34. PubMed ID: 25132654
[TBL] [Abstract][Full Text] [Related]
30. High-dose dexamethasone modulates serum cytokine profile in patients with primary immune thrombocytopenia.
Zhan Y; Zou S; Hua F; Li F; Ji L; Wang W; Ye Y; Sun L; Chen H; Cheng Y
Immunol Lett; 2014 Jul; 160(1):33-38. PubMed ID: 24657323
[TBL] [Abstract][Full Text] [Related]
31. Platelet and immune characteristics of immune thrombocytopaenia patients non-responsive to therapy reveal severe immune dysregulation.
Monzón Manzano E; Álvarez Román MT; Justo Sanz R; Fernández Bello I; Hernández D; Martín Salces M; Valor L; Rivas Pollmar I; Butta NV; Jiménez Yuste V
Br J Haematol; 2020 Jun; 189(5):943-953. PubMed ID: 31945798
[TBL] [Abstract][Full Text] [Related]
32. Efficacy and safety of thrombopoietin receptor agonists in patients with primary immune thrombocytopenia: A systematic review and meta-analysis.
Wang L; Gao Z; Chen XP; Zhang HY; Yang N; Wang FY; Guan LX; Gu ZY; Zhao SS; Luo L; Wei HP; Gao CJ
Sci Rep; 2016 Dec; 6():39003. PubMed ID: 27991534
[TBL] [Abstract][Full Text] [Related]
33. Interleukin-7 is decreased and maybe plays a pro-inflammatory function in primary immune thrombocytopenia.
Li HY; Zhang DL; Zhang X; Liu XF; Xue F; Yang RC
Platelets; 2015; 26(3):243-9. PubMed ID: 24750122
[TBL] [Abstract][Full Text] [Related]
34. Elevated Semaphorin 5A correlated with Th1 polarization in patients with chronic immune thrombocytopenia.
Lyu M; Li Y; Hao Y; Sun T; Liu W; Lyu C; Fu R; Li H; Xue F; Liu X; Zhang L; Yang R
Thromb Res; 2015 Nov; 136(5):859-64. PubMed ID: 26272304
[TBL] [Abstract][Full Text] [Related]
35. Regulation of serum thrombopoietin levels by platelets and megakaryocytes in patients with aplastic anaemia and idiopathic thrombocytopenic purpura.
Ichikawa N; Ishida F; Shimodaira S; Tahara T; Kato T; Kitano K
Thromb Haemost; 1996 Aug; 76(2):156-60. PubMed ID: 8865522
[TBL] [Abstract][Full Text] [Related]
36. New drugs for familiar therapeutic targets: thrombopoietin receptor agonists and immune thrombocytopenic purpura.
Kuter DJ
Eur J Haematol Suppl; 2008 Feb; (69):9-18. PubMed ID: 18211568
[TBL] [Abstract][Full Text] [Related]
37. Immune thrombocytopenia is associated with persistently deranged fibrosis-related seromarker profiles but low bone marrow fibrosis grades: A 2-year observational study on thrombopoietin receptor agonist treatment.
Ghanima W; Boiocchi L; Lee CS; Feng X; Geyer JT; Gudbrandsdottir S; Orazi A; Junker P; Bussel JB
Platelets; 2019; 30(2):222-228. PubMed ID: 29293383
[TBL] [Abstract][Full Text] [Related]
38. Differential mechanisms in the regulation of endogenous levels of thrombopoietin and interleukin-11 during thrombocytopenia: insight into the regulation of platelet production.
Chang M; Suen Y; Meng G; Buzby JS; Bussel J; Shen V; van de Ven C; Cairo MS
Blood; 1996 Nov; 88(9):3354-62. PubMed ID: 8896400
[TBL] [Abstract][Full Text] [Related]
39. Th1 (CXCL10) and Th2 (CCL2) chemokine expression in patients with immune thrombocytopenia.
Gu D; Chen Z; Zhao H; Du W; Xue F; Ge J; Sui T; Wu H; Liu B; Lu S; Zhang L; Yang R
Hum Immunol; 2010 Jun; 71(6):586-91. PubMed ID: 20153790
[TBL] [Abstract][Full Text] [Related]
40. [A study of immunocyte subsets and serum cytokine profiles before and after immunal suppression treatment in patients with immune thrombocytopenia].
Li W; Wang X; Li J; Liu M; Feng J
Zhonghua Nei Ke Za Zhi; 2016 Feb; 55(2):111-5. PubMed ID: 26875579
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
